Hans Denison

2.8k total citations · 2 hit papers
52 papers, 1.8k citations indexed

About

Hans Denison is a scholar working on Surgery, Gastroenterology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Hans Denison has authored 52 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Surgery, 27 papers in Gastroenterology and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Hans Denison's work include Gastroesophageal reflux and treatments (27 papers), Helicobacter pylori-related gastroenterology studies (23 papers) and Eosinophilic Esophagitis (17 papers). Hans Denison is often cited by papers focused on Gastroesophageal reflux and treatments (27 papers), Helicobacter pylori-related gastroenterology studies (23 papers) and Eosinophilic Esophagitis (17 papers). Hans Denison collaborates with scholars based in Sweden, United States and Spain. Hans Denison's co-authors include Pierre Amarenco, Carlos A. Molina, Yongjun Wang, Mikael Knutsson, Per Ladenvall, S. Claiborne Johnston, Peter J. Kahrilas, Scott Evans, Anders Himmelmänn and Gregory W. Albers and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Neurology.

In The Last Decade

Hans Denison

49 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack

2016 321 citations S. Claiborne Johnston, Pierre Amarenco et al. profile →
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA

2020 304 citations S. Claiborne Johnston, Pierre Amarenco et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hans Denison Sweden	19	743	713	582	542	386	52	1.8k
John G. Fort United States	21	1.0k 1.4×	749 1.1×	92 0.2×	417 0.8×	205 0.5×	65	2.6k
Rossana Lombardi Italy	16	281 0.4×	437 0.6×	96 0.2×	43 0.1×	209 0.5×	27	1.5k
Thomas Cuisset France	25	1.2k 1.6×	2.3k 3.3×	144 0.2×	37 0.1×	94 0.2×	67	2.6k
Alessandro Pierucci Italy	22	229 0.3×	393 0.6×	89 0.2×	27 0.0×	195 0.5×	65	1.7k
Xingyang Yi China	19	168 0.2×	732 1.0×	565 1.0×	9 0.0×	181 0.5×	73	1.2k
Kodlipet Dharmashankar United States	17	307 0.4×	807 1.1×	87 0.1×	20 0.0×	61 0.2×	26	1.3k
Yuji Miyao Japan	24	538 0.7×	1.3k 1.9×	298 0.5×	11 0.0×	223 0.6×	57	2.5k
T D Bjornsson United States	16	158 0.2×	333 0.5×	53 0.1×	31 0.1×	187 0.5×	23	979
Marek Koziński Poland	27	870 1.2×	1.5k 2.2×	137 0.2×	12 0.0×	100 0.3×	132	2.3k
Masafumi Ueno Japan	20	646 0.9×	1.2k 1.7×	65 0.1×	15 0.0×	87 0.2×	69	1.5k

Countries citing papers authored by Hans Denison

Since Specialization

Citations

This map shows the geographic impact of Hans Denison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Denison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Denison more than expected).

Fields of papers citing papers by Hans Denison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Denison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Denison. The network helps show where Hans Denison may publish in the future.

Co-authorship network of co-authors of Hans Denison

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Denison. A scholar is included among the top collaborators of Hans Denison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Denison. Hans Denison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johnston, S. Claiborne, Ritika Jain, Pierre Amarenco, et al.. (2023). Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial. BMJ Neurology Open. 5(2). e000478–e000478.

Wang, Yongjun, Yuesong Pan, Hao Li, et al.. (2022). Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack. Neurology. 99(1). e46–e54. 7 indexed citations

Johnston, S. Claiborne, Pierre Amarenco, Hans Denison, et al.. (2021). Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack. Stroke. 52(11). 3482–3489. 11 indexed citations

Evans, Scott, Mikael Knutsson, Pierre Amarenco, et al.. (2020). Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial. Clinical Trials. 17(6). 617–626. 13 indexed citations

Easton, J. Donald, Hans Denison, Scott Evans, et al.. (2019). Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial. International Journal of Stroke. 14(9). 908–914. 6 indexed citations

Wong, Ka Sing, Pierre Amarenco, Gregory W. Albers, et al.. (2018). Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial. Stroke. 49(7). 1678–1685. 18 indexed citations

Amarenco, Pierre, Gregory W. Albers, Hans Denison, et al.. (2017). Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial. The Lancet Neurology. 16(4). 301–310. 119 indexed citations

Wang, Yongjun, Kazuo Minematsu, Ka Sing Wong, et al.. (2016). Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients. Stroke. 48(1). 167–173. 18 indexed citations

Rydholm, Hans, Christian von Corswant, Hans Denison, et al.. (2016). Reducing Adverse Effects During Drug Development: The Example of Lesogaberan and Paresthesia. Clinical Therapeutics. 38(4). 946–960.

10.

Vakil, Nimish, Anna Niklasson, Hans Denison, & Anna Rydén. (2014). Symptom profile in partial responders to a proton pump inhibitor compared with treatment-naïve patients with gastroesophageal reflux disease: a post hoc analysis of two study populations. BMC Gastroenterology. 14(1). 177–177. 4 indexed citations

11.

Vakil, Nimish, Anna Niklasson, Hans Denison, & Anna Rydén. (2014). Gender differences in symptoms in partial responders to proton pump inhibitors for gastro‐oesophageal reflux disease. United European Gastroenterology Journal. 3(5). 443–452. 7 indexed citations

12.

Rydén, Anna, Hans Denison, Maria Karlsson, & Nimish Vakil. (2013). Development and validation of a patient-reported outcome instrument in partial responders to proton pump inhibitors. Scandinavian Journal of Gastroenterology. 48(9). 1018–1026. 8 indexed citations

13.

Shaheen, Nicholas J., et al.. (2013). Esophageal Mucosal Breaks in Gastroesophageal Reflux Disease Partially Responsive to Proton Pump Inhibitor Therapy. The American Journal of Gastroenterology. 108(4). 529–534. 5 indexed citations

14.

Kahrilas, Peter J., Andreas Jönsson, Hans Denison, et al.. (2012). Concomitant Symptoms Itemized in the Reflux Disease Questionnaire Are Associated With Attenuated Heartburn Response to Acid Suppression. The American Journal of Gastroenterology. 107(9). 1354–1360. 15 indexed citations

15.

Kahrilas, Peter J., Andreas Jönsson, Hans Denison, et al.. (2012). Regurgitation Is Less Responsive to Acid Suppression Than Heartburn in Patients With Gastroesophageal Reflux Disease. Clinical Gastroenterology and Hepatology. 10(6). 612–619. 81 indexed citations

16.

Shaheen, Nicholas J., et al.. (2012). Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: a randomised controlled trial. Gut. 62(9). 1248–1255. 45 indexed citations

17.

Wallerstedt, Sven, et al.. (2003). Analysis of carbohydrate-deficient transferrin (CDT) in vitreous humour as a forensic tool for detection of alcohol misuse. Forensic Science International. 137(2-3). 119–124. 16 indexed citations

18.

Denison, Hans, et al.. (1997). THE SIGNIFICANCE OF CORONARY DEATH FOR THE EXCESS MORTALITY IN ALCOHOL-DEPENDENT MEN. Alcohol and Alcoholism. 32(4). 517–526. 10 indexed citations

19.

Denison, Hans, et al.. (1995). Ischemic heart disease and epilepsy: two major causes of out-hospital natural death in male alcoholics. Forensic Science International. 73(1). 19–33. 4 indexed citations

20.

Denison, Hans & Susanna M. Wallerstedt. (1989). Bacterial Overgrowth after High-Dose Corticosteroid Treatment. Scandinavian Journal of Gastroenterology. 24(5). 561–564. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact